Literature DB >> 19294559

Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.

Myrofora Vikentiou1, Katerina Psarra, Violetta Kapsimali, Konstantinos Liapis, Michalis Michael, Konstantinos Tsionos, Evi Lianidou, Chryssa Papasteriades.   

Abstract

The cardinal feature of myelodysplastic syndromes (MDS) is dysplasia involving one or more myeloid cell lineages. In the present study, we used 4-color flow cytometric analysis to investigate dysgranulopoiesis in bone marrow specimens from 65 patients with MDS. The antigen expression patterns of total neutrophil granulocytes (TNG) and of the two distinct neutrophil granulocytic subpopulations (NGSs), NGS-1 (dimmer CD45 expression) and NGS-2 (stronger CD45 expression) identified on the side scatter (SS) vs. CD45-intensity plot, were studied. The neutrophil granulocytes from patients with MDS showed characteristic antigen expression aberrancies which were more pronounced in NGS-2 subpopulation. Studying separately the NGS-2 subpopulation with the CD16/MPO/LF combination, the low CD16(+)/MPO(+) and low CD16(+)/LF(+) percentages seemed to discriminate between lower-risk and higher-risk patients with MDS in most occasions. Furthermore, a detailed assessment of the NGS-1 and NGS-2 immunophenotypic patterns revealed early dysplastic changes, not otherwise observed by standard TNG analysis, especially in cases of lower-risk MDS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294559     DOI: 10.1080/10428190902755497

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

Review 1.  Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.

Authors:  Matteo G Della Porta; Cristina Picone
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-15       Impact factor: 2.576

2.  Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.

Authors:  Tatiana Raskovalova; Marc G Berger; Marie-Christine Jacob; Sophie Park; Lydia Campos; Carmen Mariana Aanei; Julie Kasprzak; Bruno Pereira; José Labarère; Jean-Yves Cesbron; Richard Veyrat-Masson
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.